Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.24.3
Cover - $ / shares
 3 Months Ended
Sep. 30, 2024
Nov. 06, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --06-30  
Entity File Number 001-40388  
Entity Registrant Name ANEBULO PHARMACEUTICALS, INC.  
Entity Central Index Key 0001815974  
Entity Tax Identification Number 85-1170950  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1017 Ranch Road 620 South  
Entity Address, Address Line Two Suite 107  
Entity Address, City or Town Lakeway  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78734  
City Area Code (512)  
Local Phone Number 598-0931  
Title of 12(b) Security Common Stock  
Trading Symbol ANEB  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   25,933,217
Entity Listing, Par Value Per Share $ 0.001